Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

eicosapentaenoic acid ethyl ester × Gastrointestinal × 1 year × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1 Breast 1

Conditions

Colonic Neoplasms 1

Interventions

Oxaliplatin 259 Fluorouracil 245 Bevacizumab 211 Gemcitabine 207 Leucovorin 190 pembrolizumab 185 Capecitabine 179 Irinotecan 138 Nivolumab 135 Cisplatin 131 Specimen Handling 119 Magnetic Resonance Spectroscopy 104 130-nm albumin-bound paclitaxel 103 durvalumab 96 atezolizumab 94 Radiotherapy 93 Cetuximab 89 Drug Therapy 87 Paclitaxel 86 Biopsy 76 tislelizumab 72 Albumin-Bound Paclitaxel 70 Taxes 61 Folfox protocol 61 Carboplatin 58 regorafenib 57 lenvatinib 57 Blood Specimen Collection 53 Ipilimumab 47 trifluridine tipiracil drug combination 44

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03428477 2025-04-18

EMT2

University of Leeds

Phase 3 Active not recruiting

Gastrointestinal

Colonic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡